All studies
AuthorisedTherapeutic exploratory (Phase II)Interventional

RELIEVE (RandomizEd triaL of Intravesical xEomin for incontinence via the VibE system) - a randomized, prospective, multicenter, double blind, placebo and sham controlled study to assess the safety and efficacy of NT 201 intravesical administration using Vibe System in the treatment of female participants suffering from idiopathic overactive bladder

Overactive bladder causes sudden, hard-to-control urges to pass urine, often leading to accidental leaks. A medicine called botulinum toxin can help relax the bladder muscle, but it usually requires injections with a needle. This clinical trial, named the RELIEVE study, is testing a new device called the Vibe system, which aims to deliver the medicine into the bladder more gently. The study is open to adult women with overactive bladder that does not have an obvious underlying cause. Participants will receive either the study medicine or an inactive dummy treatment (placebo). Neither the participants nor the research team will know who receives which. Over 12 weeks, participants will keep a short diary to track bladder leaks and urges. The goal is to see if this method safely reduces symptoms and improves everyday quality of life.

At a glance

Status
Authorised
Phase
Therapeutic exploratory (Phase II)
Sponsor
Vensica Medical Ltd.
Enrolment target
265
Start
20 Oct 2026

What is this study about?

Overactive bladder is a common condition where the bladder muscle contracts without warning. This gives people a sudden, urgent need to pass urine and can cause embarrassing leaks before they can reach a toilet. For many women, these symptoms make work, social plans, and sleep difficult. When standard lifestyle changes or tablets do not help, doctors often look for treatments that act directly inside the bladder.

Botulinum toxin is an established treatment that works by calming overactive bladder muscles and reducing sudden spasms. However, standard treatment usually involves passing a camera into the bladder and giving several small injections with a needle. The RELIEVE study is testing an alternative approach called the Vibe system. This system is designed to wash the medicine across the bladder lining without needles, aiming to make the procedure simpler and more comfortable.

This trial is in Phase II, which means researchers are checking how well the treatment works and ensuring it is safe. Participants are randomly put into two groups: one group receives the active medicine, and the other receives a harmless liquid with no active ingredients (a placebo). Both groups will receive the treatment through the same system so researchers can make a fair comparison.

Finding easier, less invasive ways to treat overactive bladder could offer women long-term relief from leaks without the discomfort of repeated needle injections. The findings from this trial will help doctors understand whether the Vibe system should become a routine treatment option in the NHS and worldwide.

Key takeaways

  • Tests a needle-free way to deliver botulinum toxin into the bladder.
  • Aimed at adult women with unexplained overactive bladder and leaks.
  • Compares the active medicine against a dummy liquid (placebo).
  • Tracks bladder leaks and urgency using a 3-day diary over 12 weeks.
  • Participation is voluntary and closely monitored by hospital doctors.

Who may be eligible?

This trial is open to women aged 18 and over who experience persistent symptoms of an overactive bladder, including sudden urges to pee and accidental leaks.

To take part, participants must have what doctors call 'idiopathic' overactive bladder. This simply means that tests have ruled out other obvious causes for the bladder problems, such as a severe urinary tract infection, bladder stones, or an underlying neurological condition like multiple sclerosis.

The research team will review your full medical history, current medications, and previous bladder treatments to confirm whether the study is a safe and suitable option for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am a woman aged 18 or older.
  2. I experience sudden, urgent needs to pass urine and accidental leaks.
  3. My bladder problems are not caused by an active infection or nerve condition.
  4. I am willing to attend clinic visits and keep a 3-day bladder diary.
  5. I am comfortable receiving a bladder treatment as part of a research trial.
Answer every question to see your result.

What does participation involve?

If you join the trial, you will attend an initial clinic visit where the research team will explain everything, answer your questions, and run basic health checks to ensure you are safe to take part. You will be asked to keep a simple 3-day bladder diary before treatment to record how often you leak and how urgent your trips to the toilet are.

During the treatment visit, the study liquid (either the medicine or the dummy treatment) will be introduced into your bladder using the Vibe system. You will not have to guess which one you receive, as this is chosen completely at random by a computer.

After your treatment, you will attend follow-up visits and complete further 3-day bladder diaries over the course of 12 weeks. The doctors will monitor your health, check for any side effects, and ask you questions about how your symptoms affect your daily life and well-being.

Potential risks and benefits

Taking part may help improve your bladder control and reduce leaks, although there is no guarantee you will personally benefit, especially if you receive the dummy treatment. Treatments placed inside the bladder can carry risks, such as temporary stinging when passing urine, a small risk of a urinary tract infection, or mild pelvic discomfort. The study team will monitor you closely and treat any problems quickly. Joining the trial is entirely voluntary. You have the right to withdraw at any stage, and your decision will not affect your standard NHS care.

Locations (4)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Portugal
  • —
    Unverified
    Italy
  • —
    Unverified
    Czechia
  • —
    Unverified
    Poland

Common questions

What is botulinum toxin and how does it work?

It is a purified protein commonly used in medicine to relax overactive muscles. In the bladder, it helps stop the spasms that cause sudden leaks.

What is the Vibe system?

The Vibe system is a specialised device designed to deliver medicine across the bladder wall without using traditional needle injections.

Could I receive a dummy treatment?

Yes. This study uses a placebo (an inactive liquid) to make sure any improvements are truly due to the medicine and not just the procedure itself.

Will taking part hurt?

Having a tube placed in the bladder can cause mild, temporary discomfort, but the study team uses gentle techniques to make the procedure as comfortable as possible.

Can I leave the study if I change my mind?

Yes. You can leave the trial at any time without giving a reason, and your regular doctor will continue to support your care as normal.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.